Sunaxa Pharma LLP - pharma in Hyderabad, Telangana, India. Directors, charges & compliance details.
LLPIN AAJ-5222 Incorporated 26 May 2017 ROC Hyderabad HQ Hyderabad, Telangana, India
Converted to LLP Limited Liability Partnership pharma
Data last updated
Contribution obligation
₹5.3 Lakh
As per LLP agreement
Open charges
₹1.65 Cr
Secured borrowings
LLP age
9 yrs
Est. 2017
Employees · EPFO
5
Provident fund records
Designated partners
4
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2024
Balance sheet date
LLP status
Converted and Dissolved
MCA master data

About Sunaxa Pharma LLP

Data last updated:

Sunaxa Pharma LLP was a limited liability partnership (LLP) based in Hyderabad, Telangana, India. The LLP has been converted into a company and no longer exists as an LLP. For the latest details, refer to the successor company. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 May 2017.

The LLP was registered with the Registrar of Companies (ROC), Hyderabad, under LLPIN AAJ-5222. Its GSTIN is 36ADJFS1775J1ZL (Telangana).

The LLP had a total obligation of contribution of ₹5.3 Lakh. It was led by designated partners including Veerareddy Vallapureddy and Madhu Madiga.

Its latest statement of accounts is for the year ended 31 March 2024. The registered office was at Hyderabad, Telangana.

The LLP has about 5 employees on its provident fund (EPFO) records.

As per MCA filings, the LLP has open charges of ₹1.65 Cr on record. Court records list 1 case involving the LLP.

Company Details of Sunaxa Pharma LLP
LLPIN AAJ-5222
Incorporation Date 26 May 2017
Total Obligation of Contribution ₹5.3 Lakh
ROC Hyderabad
Company Status Converted and Dissolved
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2024
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Sy No. 37/P 38/P 39/P H No. 2 – 3 – 17 Flat No. 103, 1st Floor Abhinandana Jewel Lanco Hills Road Hanuman Nagar Manikonda, Hyderabad, Telangana, India – 500089
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Sunaxa Pharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Sunaxa Pharma LLP report

Financials, compliance, directors, charges, ownership and filings for Sunaxa Pharma LLP in one report.

Financials from FY 2018 Directors & ownership Charges & compliance

Financials of Sunaxa Pharma LLP FY 2024 filings available

Financial Statement Summary of Sunaxa Pharma LLP

Statement of Account and SolvencyFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income and Expenditure
Turnover••••••••••••••••••••
Other Income••••••••••••••••••••
Total Income••••••••••••••••••••
Purchases and Direct Costs••••••••••••••••••••
Personnel Expenses••••••••••••••••••••
Administrative Expenses••••••••••••••••••••
Interest••••••••••••••••••••
Depreciation••••••••••••••••••••
Total Expenses••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax••••••••••••••••••••
Profit After Tax••••••••••••••••••••
Profit Transferred to Partners••••••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Secured Loans••••••••••••••••••••
Unsecured Loans••••••••••••••••••••
Trade Payables••••••••••••••••••••
Other Liabilities and Provisions••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Loans and Advances••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Sunaxa Pharma LLP

Statement of Account and SolvencyFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
Net Profit Margin••••••••••••••••••••
Return on Partners' Funds••••••••••••••••••••
Return on Assets••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Debt to Partners' Funds••••••••••••••••••••
Interest Coverage••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Turnover Growth••••••••••••••••••••
Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Sunaxa Pharma are in the company report.

Premium access

Financial statements from FY 2018

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Sunaxa Pharma LLP

Sunaxa Pharma has 4 current designated partners and 5 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Designated Partners (as last reported)
NameDesignationAppointment DateTenureStatus
Veerareddy VallapureddyDesignated Partner29 Jan 20188 Years 8 MonthsAs last reported
Madhu MadigaDesignated Partner15 Jun 20179 Years 4 MonthsAs last reported
Bharath Kumar Karnam BhupasamudhramDesignated Partner15 Jun 20179 Years 4 MonthsAs last reported
Manasa Reddy DevireddyDesignated Partner12 Sep 20242 Years 1 MonthsAs last reported

Charges & Borrowings of Sunaxa Pharma LLP

Open charges
₹1.65 Cr
Satisfied charges
None
Breakdown by lending institutions
Icici Bank Limited₹1.65 Cr
Latest charge details
DateLenderAmountStatus
29 Nov 2021Icici Bank Limited₹1.65 CrOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Sunaxa Pharma LLP

Employment history and EPFO contributions of people linked to Sunaxa Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Sunaxa Pharma LLP

Sunaxa Pharma LLP has 9 designated partner changes on record since 2017: 4 appointments and 5 cessations. The latest: Bharath Kumar Karnam Bhupasamudhram ceased to be Designated Partner on 12 Sep 2024.

AGM
Sunaxa Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Ceased
Bharath Kumar Karnam Bhupasamudhram ceased to be Designated Partner.
Ceased
Madhu Madiga ceased to be Designated Partner.
Appointed
Manasa Reddy Devireddy was appointed as Designated Partner.
Filing
Sunaxa Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Icici Bank Limited of Rs. 165.00 Lakh registered on 29 Nov 2021 with Charge ID 100514000 was modified on 27 Sep 2022.
Charges
A charge with Icici Bank Limited amounted to Rs. 165.00 Lakh with Charge ID 100514000 was registered on 29 Nov 2021.
Ceased
Udaya Kiran Perla ceased to be Designated Partner.
Ceased
Santhi Yamaka ceased to be Partner.
Appointed
Veerareddy Vallapureddy was appointed as Designated Partner.
Ceased
Srinivasa Reddy Devireddy ceased to be Designated Partner.
Appointed
Bharath Kumar Karnam Bhupasamudhram was appointed as Designated Partner.

2 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Sunaxa Pharma LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Sunaxa Pharma LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Sunaxa Pharma LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Sunaxa Pharma LLP

Sunaxa Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36ADJFS1775J1ZLTelanganaActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Sunaxa Pharma LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunaxa Pharma LLP

Sunaxa Pharma has been converted into a company - the business changed its legal structure from a Limited Liability Partnership to a company. The LLP no longer exists in its previous form. For the latest information, refer to the successor company registered with MCA.

Sunaxa Pharma was a limited liability partnership based in Hyderabad, Telangana, India. The LLP worked in drug formulation and development, within the pharma industry. It was incorporated on 26 May 2017 and is registered under LLPIN AAJ-5222. For the latest details, refer to the successor company.

The LLPIN (Limited Liability Partnership Identification Number) of Sunaxa Pharma is AAJ-5222. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Sunaxa Pharma had 4 designated partners:

Sunaxa Pharma was incorporated on 26 May 2017. It is registered with the Registrar of Companies, Hyderabad.

The registered office of Sunaxa Pharma is at Sy No. 37P 38P 39P H No. 2 – 3 – 17 Flat No. 103, 1st Floor Abhinandana Jewel Lanco Hills Road Hanuman Nagar Manikonda, Hyderabad, Telangana, India – 500089.

The total obligation of contribution is ₹5.3 Lakh.

The GSTIN of Sunaxa Pharma is 36ADJFS1775J1ZL, registered in Telangana.

Sunaxa Pharma operated in the pharma industry, in the drug formulation and development segment.

Sunaxa Pharma has 1 court case on record.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available